保寶龍科技(01861.HK)擬1.2億港元收購廣州歐亞氣霧劑與日化用品30%股權
格隆匯 9 月 4日丨保寶龍科技(01861.HK)公告,於2020年9月4日,買方中國醫美生物科技有限公司(公司間接全資附屬公司)與賣方歐亞行實業有限公司訂立買賣協議,據此,買方有條件同意收購而賣方有條件同意出售目標公司廣州歐亞氣霧劑與日化用品製造有限公司30%已發行股本,現金代價為1.2億港元。
於完成後,買方於目標公司股權將由70%增至100%,以及目標公司財務資料將繼續於集團財務報表綜合入賬。目標公司主要從事個人護理產品(例如洗手液、泡沫洗面奶、防曬霜、保濕霜、除臭劑及洗手液)及其他產品(包括家用產品(例如油漆及地板蠟))的設計、開發、製造及銷售。
董事(不包括獨立非執行董事,彼等將於審閲獨立財務顧問函件後形成其意見)認為,收購事項代表集團進一步鞏固其於目標公司利益機會,賦予集團更大靈活性實施一體化策略以釋放目標公司業務的潛力及價值以及為集團的現金流量及盈利能力帶來貢獻(倘目標公司日後繼續進行業務),以及買賣協議條款公平合理及符合公司及股東整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.